D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years

Autor: Turkova, Anna, Chan, Man K., Kityo, Cissy, Kekitiinwa, Adeodata R., Musoke, Philippa, Violari, Avy, Variava, Ebrahim, Archary, Moherndran, Cressey, Tim R., Chalermpantmetagul, Suwalai, Sawasdichai, Kanokkorn, Ounchanum, Pradthana, Kanjanavanit, Suparat, Srirojana, Sakulrat, Srirompotong, Ussanee, Welch, Steven, Bamford, Alasdair, Epalza, Cristina, Fortuny, Clàudia, Colbers, Angela, Nastouli, Eleni, Walker, Simon, Carr, Dan, Conway, Magda, Spyer, Moira J., Parkar, Nazia, White, Iona, Nardone, Alessandra, Thomason, Margaret J., Ferrand, Rashida A., Giaquinto, Carlo, Ford, Deborah
Zdroj: In Contemporary Clinical Trials July 2024 142
Databáze: ScienceDirect
Externí odkaz: